1-3 of 3
Martin Felices
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality

Shernan G. Holtan, Constanza Savid-Frontera, Kelly Walton, Anne A. Eaton, Connor Demorest, Andrea Hoeschen, Ling Zhang, Kayla Reid, Tony Kurian, Zena Sayegh, Estefania Julia, Joseph Maakaron, Veronika Bachanova, Najla El Jurdi, Margaret L. MacMillan, Daniel J. Weisdorf, Martin Felices, Jeffrey S. Miller, Bruce R. Blazar, Marco L. Davila, Brian C. Betts
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (6): 1114–1124.
https://doi.org/10.1158/1078-0432.CCR-22-2837
Published: 14 March 2023
View article titled, Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality
Open the PDF for Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality in another window
Includes: Supplementary data
Journal Articles

Targeting KIR Blockade in Multiple Myeloma: Trouble in Checkpoint Paradise?

Martin Felices, Jeffrey S. Miller
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (21): 5161–5163.
https://doi.org/10.1158/1078-0432.CCR-16-1582
Published: 31 October 2016
View article titled, Targeting KIR Blockade in Multiple Myeloma: Trouble in Checkpoint Paradise?
Open the PDF for Targeting KIR Blockade in Multiple Myeloma: Trouble in Checkpoint Paradise? in another window
Journal Articles

IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function

Daniel A. Vallera, Martin Felices, Ron McElmurry, Valarie McCullar, Xianzheng Zhou, Joerg Uwe Schmohl, Bin Zhang, Alexander J. Lenvik, Angela Panoskaltsis-Mortari, Michael R. Verneris, Jakub Tolar, Sarah Cooley, Daniel J. Weisdorf, Bruce R. Blazar, Jeffrey S. Miller
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (14): 3440–3450.
https://doi.org/10.1158/1078-0432.CCR-15-2710
Published: 14 July 2016
View article titled, IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33<sup>+</sup> Targets While Also Inducing Persistence, <em>In Vivo</em> Expansion, and Enhanced Function
Open the PDF for IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33<sup>+</sup> Targets While Also Inducing Persistence, <em>In Vivo</em> Expansion, and Enhanced Function in another window
Includes: Supplementary data